Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Long-Term Investments (2022 - 2023)

Envoy Medical's Long-Term Investments history spans 2 years, with the latest figure at $44.6 million for Q2 2023.

  • For Q2 2023, Long-Term Investments changed N/A year-over-year to $44.6 million; the TTM value through Jun 2023 reached $44.6 million, changed N/A, while the annual FY2022 figure was $430.0 million, N/A changed from the prior year.
  • Long-Term Investments for Q2 2023 was $44.6 million at Envoy Medical, down from $430.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $430.0 million in Q4 2022 and bottomed at $44.6 million in Q2 2023.